NDC 66302-101

Remodulin

Treprostinil

Remodulin is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by United Therapeutics Corporation. The primary component is Treprostinil.

Product ID66302-101_14e0bedf-b5f3-45a5-9de5-863ddb53e7b9
NDC66302-101
Product TypeHuman Prescription Drug
Proprietary NameRemodulin
Generic NameTreprostinil
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2002-05-22
Marketing CategoryNDA / NDA
Application NumberNDA021272
Labeler NameUnited Therapeutics Corporation
Substance NameTREPROSTINIL
Active Ingredient Strength20 mg/20mL
Pharm ClassesProstacycline Vasodilator [EPC],Prostaglandins I [CS],Vasodilation [PE]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 66302-101-01

1 VIAL in 1 BOX (66302-101-01) > 20 mL in 1 VIAL
Marketing Start Date2002-05-22
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 66302-101-01 [66302010101]

Remodulin INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA021272
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitML
Marketing Start Date2002-05-22

Drug Details

Active Ingredients

IngredientStrength
TREPROSTINIL20 mg/20mL

OpenFDA Data

SPL SET ID:6c80bb38-e8db-4138-9f0d-dbbf9c673185
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 352214
  • 349410
  • 540930
  • 349408
  • 349409
  • 352211
  • 352213
  • 352212
  • 349407
  • Pharmacological Class

    • Prostacycline Vasodilator [EPC]
    • Prostaglandins I [CS]
    • Vasodilation [PE]

    NDC Crossover Matching brand name "Remodulin" or generic name "Treprostinil"

    NDCBrand NameGeneric Name
    66302-101Remodulintreprostinil
    66302-102Remodulintreprostinil
    66302-105RemodulinRemodulin
    66302-110RemodulinRemodulin
    0703-0666TreprostinilTreprostinil
    0703-0676TreprostinilTreprostinil
    0703-0686TreprostinilTreprostinil
    0703-0696TreprostinilTreprostinil
    0781-3420Treprostiniltreprostinil
    0781-3425Treprostiniltreprostinil
    0781-3427Treprostiniltreprostinil
    0781-3430Treprostiniltreprostinil
    42023-206TreprostinilTreprostinil
    42023-207TreprostinilTreprostinil
    42023-208TreprostinilTreprostinil
    42023-209TreprostinilTreprostinil
    62332-514TreprostinilTreprostinil
    62332-515TreprostinilTreprostinil
    62332-516TreprostinilTreprostinil
    62332-517TreprostinilTreprostinil

    Trademark Results [Remodulin]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    REMODULIN
    REMODULIN
    76173227 2618835 Live/Registered
    United Therapeutics Corporation
    2000-11-30

    © 2022 FDA.report
    This site is not affiliated with or endorsed by the FDA.